FDA Approves Emergent BioSolutions’ (NYSE: EBS) Smallpox Vaccine for High-Risk Mpox Patients
The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions’ (NYSE: EBS) smallpox vaccine for use in people […]
NYSE: EBS
Emergent BioSolutions (NYSE: EBS) Stock Skyrockets on Q1 Earnings Beat and Strategic Financial Moves
Emergent BioSolutions (NYSE: EBS) stock soared over 70% in intraday trading Thursday following the release of first-quarter financial results. The
Emergent (NYSE: EBS) Stock Skyrockets as Former Bausch + Lomb CEO Takes Helm
Emergent BioSolutions (NYSE: EBS) stock soared on Wednesday with the appointment of the former Bausch + Lomb CEO as its
Emergent (NYSE: EBS) Stock Skyrockets as Former Bausch + Lomb CEO Takes Helm Read More »
